Background and aims: Diabetes mellitus (DM) has been associated with higher incidence of severe cases of COVID-19 in hospitalized patients, but it is unknown whether DM is a risk factor for the overall COVID-19 incidence. The aim of present study was to investigate whether there is an association of DM with COVID-19 prevalence and case fatality, and between different DM medications and risk for COVID-19 infection and death. Methods and results: retrospective observational study on all SARS-CoV-2 positive (SARS-CoV-2+) cases and deaths in Sicily up to 2020, May 14th. No difference in COVID-19 prevalence was found between people with and without DM (RR 0.92 [0.79-1.09]). Case fatality was significantly higher in SARS-CoV-2+ with DM (RR 4.5 [3.55-5.71]). No diabetes medication was associated with differences in risk for SARS-Cov2 infection. Conclusions: in Sicily, DM was not a risk factor for COVID-19 infection, whereas it was associated with a higher case fatality.

Silverii GA, M.M. (2021). Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 396-398 [10.1016/j.numecd.2020.09.028].

Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.

Cernigliaro A;Guarnotta V;Conti M;Giordano C;
2021-01-01

Abstract

Background and aims: Diabetes mellitus (DM) has been associated with higher incidence of severe cases of COVID-19 in hospitalized patients, but it is unknown whether DM is a risk factor for the overall COVID-19 incidence. The aim of present study was to investigate whether there is an association of DM with COVID-19 prevalence and case fatality, and between different DM medications and risk for COVID-19 infection and death. Methods and results: retrospective observational study on all SARS-CoV-2 positive (SARS-CoV-2+) cases and deaths in Sicily up to 2020, May 14th. No difference in COVID-19 prevalence was found between people with and without DM (RR 0.92 [0.79-1.09]). Case fatality was significantly higher in SARS-CoV-2+ with DM (RR 4.5 [3.55-5.71]). No diabetes medication was associated with differences in risk for SARS-Cov2 infection. Conclusions: in Sicily, DM was not a risk factor for COVID-19 infection, whereas it was associated with a higher case fatality.
2021
Silverii GA, M.M. (2021). Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 396-398 [10.1016/j.numecd.2020.09.028].
File in questo prodotto:
File Dimensione Formato  
Silverii covid 2021.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 270.97 kB
Formato Adobe PDF
270.97 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/541512
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 32
social impact